Test Code LAB116 Prostate Specific Antigen (PSA), Diagnostic
Useful For
Elevated serum PSA concentrations have been reported in patients with prostate cancer, benign prostatic hypertrophy or inflammatory conditions of other adjacent genitourinary tissues, but not in apparently healthy men, men with non-prostatic carcinoma, apparently healthy women or women with cancer. PSA may serve as an accurate marker for assessing response to treatment in patients with stages B2 and D1 prostatic cancer. Serial measurement of PSA concentrations can be an important tool in monitoring patients with prostatic cancer and in determining the potential and actual efficacy of surgery and other therapies. This test measures total PSA (see notes regarding free PSA).
Results from other manufactures or methodologies may vary in concentrations due to differences in reagent specificity and should not be used interchangeably. When performing serial samples over time, it is recommended that the same method be used, unless “re-baselined” with another method.
Performing Laboratory
Asante Rogue Regional Medical Center (ARRMC)
Performing Department
Chemistry
Specimen Required
Manipulation of the prostate may increase the PSA value
DO NOT collect following a digital rectal exam, prostatic massage, or transurethral ultrasound
Specimen Minimum Volume
1.0 mL
Specimen Stability Information
Centrifuge and refrigerate within 2 hours of collection
Centrifuged SST is stable up to 24 hours at 2° to 8° C. Aliquot and freeze serum if testing to be further delayed
Reject Due To
- Hemolysis
- Quantity not sufficient (QNS)
- Lack of Two Patient Identifiers:
- 1-Patient’s First & Last name
- 2-Patient’s Date of Birth
- Specimen stability time exceeded
Day(s) Performed
Monday through Sunday
Method Name
Chemiluminescence (CLIA) Testing performed on Beckman Coulter DXI600
CPT Code Information
- 84153 (diagnostic) Prostate specific antigen; total
- G0103 Prostate cancer screening; prostate specific antigen test
Billing Code
3010023